These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 942800)

  • 21. Effects of 6-hydroxydopamine and amphetamine on rat mothering behavior and offspring development.
    Piccirillo M; Alpert JE; Cohen DJ; Shaywitz BA
    Pharmacol Biochem Behav; 1980 Sep; 13(3):391-5. PubMed ID: 7422694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postnatal lead acetate exposure in rats: possible relationship to minimal brain dysfunction.
    Sobotka TJ; Cook MP
    Am J Ment Defic; 1974 Jul; 79(1):5-9. PubMed ID: 4473893
    [No Abstract]   [Full Text] [Related]  

  • 23. Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update.
    Prince J
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S39-45. PubMed ID: 18480676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine.
    Smith RD; Cooper BR; Breese GR
    J Pharmacol Exp Ther; 1973 Jun; 185(3):609-19. PubMed ID: 4145870
    [No Abstract]   [Full Text] [Related]  

  • 25. The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats.
    Tamburella A; Micale V; Mazzola C; Salomone S; Drago F
    Eur J Pharmacol; 2012 May; 683(1-3):148-54. PubMed ID: 22426162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
    Solanto MV
    Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
    [No Abstract]   [Full Text] [Related]  

  • 27. Dopamine and norepinephrine enhancement in discrete rat brain regions following neonatal 6-hydroxydopamine treatment.
    Oke A; Keller R; Adams RN
    Brain Res; 1978 Jun; 148(1):245-50. PubMed ID: 656929
    [No Abstract]   [Full Text] [Related]  

  • 28. Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder.
    Moran-Gates T; Zhang K; Baldessarini RJ; Tarazi FI
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):439-44. PubMed ID: 15817135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of neonatal treatment with 6-hydroxydopamine and endocrine disruptors on motor activity and gene expression in rats.
    Masuo Y; Ishido M; Morita M; Oka S
    Neural Plast; 2004; 11(1-2):59-76. PubMed ID: 15303306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of nociceptive response to chemical, mechanical, and thermal stimuli in adolescent rats with neonatal dopamine depletion.
    Ogata M; Noda K; Akita H; Ishibashi H
    Neuroscience; 2015 Mar; 289():43-55. PubMed ID: 25592423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paradoxical effects of amphetamine on preweanling and postweanling rats.
    Campbell BA; Randall PJ
    Science; 1977 Mar; 195(4281):888-91. PubMed ID: 557236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenergic hyperactivity and metanephrine excess in the nucleus accumbens after prefrontocortical dopamine depletion.
    Espejo EF; Miñano J
    J Neurophysiol; 2001 Mar; 85(3):1270-4. PubMed ID: 11247995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Learning impairment in rats after 6-hydroxydopamine-induced depletion of brain catecholamines.
    Mason ST; Iverson SD
    Nature; 1974 Apr; 248(5450):697-8. PubMed ID: 4151498
    [No Abstract]   [Full Text] [Related]  

  • 38. Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD).
    Caballero M; Núñez F; Ahern S; Cuffí ML; Carbonell L; Sánchez S; Fernández-Dueñas V; Ciruela F
    Neurosci Lett; 2011 Apr; 494(1):44-8. PubMed ID: 21362462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Spontaneous motor activity and radial-maze learning in rats neonatally treated with 6-hydroxydopamine].
    Iwasaki T; Takasuna M
    Yakubutsu Seishin Kodo; 1986 Dec; 6(4):381-8. PubMed ID: 3103348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ascending catecholamine pathways and amphetamine-induced locomotor activity: importance of dopamine and apparent non-involvement of norepinephrine.
    Roberts DC; Zis AP; Fibiger HC
    Brain Res; 1975 Aug; 93(3):441-54. PubMed ID: 1236760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.